Viewing nowCombinationVaikra Tablets 375mg (Amoxicillin·Clavulanate Potassium)
Amoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Bionext Co., Ltd.

MFDS item code 201707117 · Approved 2017.09.19 · Insurance code 643104400
Treatment of respiratory, genitourinary, skin and soft tissue, bone, and dental infections
This medication is used for various bacterial infections. It is effective for respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, and lung abscess. It is also used for upper respiratory infections such as tonsillitis, sinusitis, and otitis media. It helps treat infections in the urogenital system including cystitis, urethritis, pyelonephritis, pelvic infections, and gonorrhea. It is effective for skin and soft tissue infections including boils, abscesses, and wound infections as well as bone infections such as osteomyelitis. Additionally, it is used for dental infections, improving various bacterial infectious diseases.
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally every 8 hours 3 times daily. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is needed in patients with a creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer 250 mg/125 mg or 500 mg/125 mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250 mg/125 mg or 500 mg/125 mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250 mg/125 mg or 500 mg/125 mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate decrease).
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally every 8 hours 3 times daily. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg per dose. Children: Reduce the dose in the same manner.
This medication should not be administered to patients with a history of hypersensitivity to beta-lactam antibiotics, particularly penicillins. Patients with infectious mononucleosis or lymphocytic leukemia are at higher risk of rashes, so caution is necessary. Patients with a history of liver dysfunction or jaundice should also avoid using this medication, as symptoms may recur. Caution should be exercised in patients with liver impairment due to the possibility of worsening liver function. Patients with moderate to severe renal impairment may have elevated blood drug concentrations, requiring adjustment of dosing intervals. Patients with allergies may experience bronchial asthma, rashes, or urticaria, requiring vigilance. Patients exhibiting gastrointestinal symptoms such as vomiting or diarrhea may have inadequate drug absorption, necessitating caution. Gastrointestinal side effects like diarrhea, vomiting, and abdominal pain may occur, and in severe cases, pseudomembranous colitis may occur, meaning any abnormal symptoms warrant immediate consultation with a physician. Liver function abnormalities such as hepatitis or jaundice can occur rarely, so regular liver function tests are advised. Severe allergic reactions such as skin rashes, anaphylaxis, and angioedema may occur, and immediate cessation of administration and notification to healthcare professionals is required upon symptom onset. Hematological abnormalities like leukopenia and thrombocytopenia may occur rarely, needing monitoring through blood tests. Neurological symptoms like dizziness, headaches, and, rarely, seizures may occur, requiring special caution in patients with kidney function impairment. Patients with renal problems are at risk of acute renal failure, necessitating regular monitoring of renal function. During antibiotic use, dysbiosis may occur, leading to conditions like candidiasis; therefore, patients should be alert for symptoms. Vitamin K deficiency may lead to bleeding tendencies, especially in the elderly or those at risk of vitamin deficiency, requiring caution. It is advisable not to use this medication during the first trimester of pregnancy, and breastfeeding mothers should discontinue if adverse symptoms develop in infants. It is not recommended for children under 12 years of age or those weighing less than 40 kg. Elderly patients are at higher risk of adverse reactions due to declining physiological functions, requiring careful dose and interval adjustments. This medication may interact with other drugs, so patients should inform their physician or pharmacist of any concurrent medications. In cases of overdose, gastrointestinal symptoms and renal function deterioration may occur, necessitating prompt medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent moisture entry and at a cool temperature between 1°C and 25°C. Proper storage ensures the medication does not deteriorate and remains safe for use.
White or almost white oval film-coated tablets
100 tablets/box [(10 tablets/PTP×10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Bionext Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 125mg · Dilute Potassium Clavulanate 107.76mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Dong Sung Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.